The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.55
Bid: 9.30
Ask: 9.80
Change: -0.05 (-0.52%)
Spread: 0.50 (5.376%)
Open: 9.60
High: 9.60
Low: 9.55
Prev. Close: 9.60
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 18th Sep 2018 16:19

Wednesday 19 September 
KingfisherHalf Year Results
Babcock InternationalTrading Statement 
Stagecoach GroupTrading Statement 
RA InternationalHalf Year Results
Yu GroupHalf Year Results
Alliance PharmaHalf Year Results
Cello Health GroupHalf Year Results
Accesso TechnologyHalf Year Results
Greencoat RenewablesHalf Year Results
ErgomedHalf Year Results
QuixantHalf Year Results
EKFHalf Year Results
Thursday 20 September 
IG GroupQ1 Results
Kier GroupHalf Year Results
SOCO InternationalHalf Year Results
Safestyle UKHalf Year Results
City PubHalf Year Results
hVIVOHalf Year Results
LamprellHalf Year Results
Brooks Macdonald GroupFull Year Results
ScisysHalf Year Results
Venture Life GroupHalf Year Results
Inland HomesFull Year Results
Modern WaterHalf Year Results
French ConnectionHalf Year Results
FW ThorpeFull Year Results
Friday 21 September 
Smiths GroupFull Year Results
SIGHalf Year Results
M&C SaatchiHalf Year Results
Triple Point Social HousingHalf Year Results
New Star Investment TrustFull Year Results
Monday 24 September 
Pennon GroupTrading Statement 
Gama AviationHalf Year Results
XLMediaHalf Year Results
KapeHalf Year Results
MaxcyteHalf Year Results
InstemHalf Year Results
Trinity ExplorationHalf Year Results
River & Mercantile GroupFull Year Results
DeltexHalf Year Results
Tuesday 25 Setember 
NextHalf Year Results
AG BarrHalf Year Results
Close BrothersFull Year Results 
OsiriumHalf Year Results
FireAngel SafetyHalf Year Results
Card FactoryHalf Year Results
S&UHalf Year Results
Keystone LawHalf Year Results
Altitude GroupHalf Year Results
Animalcare GroupHalf Year Results
EbiquityHalf Year Results
Menhaden CapitalHalf Year Results
WANdiscoHalf Year Results
Mortgage Advice BureauHalf Year Results
Learning TechnologiesHalf Year Results
Thomas Cook GroupTrading Statement 
United UtilitiesTrading Statement 
Hotel Chocolat GroupFull Year Results 
Harvey Nash GrouipHalf Year Results
Moss BrosHalf Year Results
SSEFinancial Outlook Statement
Blancco Technology GroupFull Year Results 
ScancellFull Year Results 
  

More News
20 Nov 2019 10:01

Scancell To Receive New European Patent For Moditope Product

Scancell To Receive New European Patent For Moditope Product

Read more
23 Oct 2019 10:48

Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive

Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive

Read more
5 Sep 2019 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Friday 6 SeptemberMySale Group (re share placing)Berkeley GroupGreene 9 African Oil & 10 11 Design

Read more
4 Sep 2019 08:58

Scancell signs collaboration agreement with antibody technology company

(Sharecast News) - Cancer treatment developer Scancell has inked its first collaboration agreement with a "leading" antibody technology company for its new platform technology, AvidiMab.

Read more
20 Aug 2019 10:59

Scancell losses deepen as it presses on with development

(Sharecast News) - Novel immunotherapies developer Scancell Holdings reported a deeper operating loss in its final results on Tuesday, to £6.73m compared to £4.91m in the 2018 financial year.

Read more
20 Aug 2019 10:59

Scancell Annual Loss Widens Amid Product Pipeline Development

(Alliance News) - Immunotherapy firm Scancell Holdings PLC on Tuesday said its loss widened on higher development costs, while it is making strong progress on advancing its the 12 months to the of

Read more
19 Aug 2019 09:33

Scancell to begin SCIB1 UK trial as FDA issues linger in US

(Sharecast News) - Immunotherapy developer Scancell announced the initiation of and further updates to the 'SCIB1' phase 2 trial in patients with metastatic melanoma also receiving the checkpoint inhibitor 'pembrolizumab' (Keytruda) on Monday.

Read more
13 Aug 2019 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 14 August AvastHalf Year ResultsLookersHalf Year BeattyHalf Year Year

Read more
1 Jul 2019 14:42

Scancell Progresses Trials In "Busy And Productive" Six Months

(Alliance News) - Scancell Holdings PLC said on Monday it has been a "busy and productive" six months for the company.The company said that active patient recruitment for the two

Read more
18 Jun 2019 14:40

Scancell Appoints Vulpes Investment Management Co-Founder To Board

(Alliance News) - Scancell Holdings PLC on Tuesday said it has appointed Vulpes Investment Management Co-Founder & Portfolio Manager Martin Diggle to its board.Diggle joins the cancer a

Read more
13 Jun 2019 13:48

Scancell Shares Jump 30% As Vulpes Invests GBP4 Million (ALLISS)

(Alliance News) - Scancell Holdings PLC's shares soared Thursday as it received GBP3.9 million from a new investor.Scancell shares were up 31% in afternoon trade at a price of 7.00 Life

Read more
21 May 2019 13:25

N4 Pharma Appoints John Chiplin as Non-Executive Chairman

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said it appointed John Chiplin as non-executive chair of the company with immediate effect.Furthermore, the pharmaceutical firm appointed a

Read more
20 May 2019 11:03

Scancell partnership with Cancer Research moves closer to clinic

(Sharecast News) - Immunotherapy developer Scancell Holdings updated the market on its clinical development partnership with Cancer Research UK for the development of the ;ImmunoBody' vaccine, SCIB2, as a potential treatment for patients with solid tumours, including non-small cell lung cancer (NSCLC), on Monday.

Read more
20 May 2019 11:02

Scancell Says Cancer Vaccine SCIB2 Will Be Given Using New Formulation

LONDON (Alliance News) - Scancell Holdings PLC said Monday cancer vaccine SCIB2 is to be administered using a new nanoparticle formulation in an early stage trial.Shares in Scancell were up

Read more
10 May 2019 10:49

Scancell Creates Advisory Board And Prepares For Drug Trials

LONDON (Alliance News) - Scancell Holdings PLC on Friday said it has established a clinical advisory board and has begun manufacturing and toxicity testing on its tumour drug in immunotherapy were

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.